Population Pharmacokinetics and Dosing Optimization of Azithromycin in Children with Community-Acquired Pneumonia | Zendy

Yi Zheng | Zendy; Shuping Liu | Zendy; Baoping Xu | Zendy; Zhong-Ren Shi | Zendy; Kai Wang | Zendy; Jinbin Yang | Zendy; Xin Huang | Zendy; BoHao Tang | Zendy; Xingkai Chen | Zendy; Haiyan Shi | Zendy; Yue Zhou | Zendy; YueE Wu | Zendy; Hui Qi | Zendy; Evelyne JacqzAigrain | Zendy; Adong Shen | Zendy; Wei Zhao | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Population Pharmacokinetics and Dosing Optimization of Azithromycin in Children with Community-Acquired Pneumonia

Author(s) -

Yi Zheng,

Shuping Liu,

Baoping Xu,

Zhong-Ren Shi,

Kai Wang,

Jinbin Yang,

Xin Huang,

BoHao Tang,

Xingkai Chen,

Haiyan Shi,

Yue Zhou,

YueE Wu,

Hui Qi,

Evelyne JacqzAigrain,

Adong Shen,

Wei Zhao

Publication year - 2018

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.00686-18

Subject(s) - pharmacokinetics , azithromycin , medicine , dosing , population , nonmem , pharmacology , antibiotics , chemistry , environmental health , biochemistry

Azithromycin is extensively used in children with community-acquired pneumonia (CAP). Currently, the intravenous azithromycin is used off-label in children partly due to lacking of pharmacokinetic data.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research